Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000904454-15-000451
Filing Date
2015-07-06
Accepted
2015-07-06 18:11:17
Documents
1
Period of Report
2015-07-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 3726
  Complete submission text file 0000904454-15-000451.txt   5949
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Reporting) CIK: 0000200406 (see all company filings)

State of Incorp.: NJ | Fiscal Year End: 1212
Type: 3 | Act: 34 | File No.: 001-33095 | Film No.: 15974563
SIC: 2834 Pharmaceutical Preparations

Mailing Address 410 GEORGE STREET NEW BRUNSWICK NJ 08901
Business Address 410 GEORGE STREET NEW BRUNSWICK NJ 08901 (732) 524-3218
Johnson & Johnson Innovation - JJDC, Inc. (Reporting) CIK: 0000924020 (see all company filings)

State of Incorp.: NJ
Type: 3 | Act: 34 | File No.: 001-33095 | Film No.: 15974562

Mailing Address 300 GEORGE STREET NEW HAVEN CT 06511
Business Address 300 GEORGE STREET NEW HAVEN CT 06511 203-624-7000
ACHILLION PHARMACEUTICALS INC (Issuer) CIK: 0001070336 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations